Citation Impact
Citing Papers
Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters
2010
Nanoparticles: Properties, applications and toxicities
2017 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Targeted therapies for breast cancer
2011
Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer
2014
Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
2010
Breast cancer
2019 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
2012
Lapatinib and breast cancer: current indications and outlook for the future
2010
A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine
2012
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Intracellular Delivery System for Antibody–Peptide Drug Conjugates
2015 StandoutNobel
Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
2012
New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available
2011
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
2016
Biomolecular condensates: organizers of cellular biochemistry
2017 Standout
Cancer drug delivery in the nano era: An overview and perspectives
2017
Silk-based stabilization of biomacromolecules
2015
LC–MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1)
2017
Critical evaluation of fast size exclusion chromatographic separations of protein aggregates, applying sub-2μm particles
2013
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics
2013
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
2016 Standout
Linker Technologies for Antibody–Drug Conjugates
2013
Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
2015
Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals
2008
Immunoconjugates and long circulating systems: Origins, current state of the art and future directions
2012
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Antibody drug conjugates
2014
Cancer stem cells revisited
2017 Standout
Immunogenicity of therapeutic proteins: Influence of aggregation
2013
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
2012
Biogenic selenium nanoparticles: current status and future prospects
2016 Standout
Rapid online buffer exchange for screening of proteins, protein complexes and cell lysates by native mass spectrometry
2020 StandoutNobel
Immunoconjugates Against Solid Tumors: Mind the Gap
2011
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Stability of Protein Pharmaceuticals: An Update
2010
8thAnnual European Antibody Congress 2012
2013
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Peptide therapeutics: current status and future directions
2014 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers
2015
Nanoparticle tracking analysis of particle size and concentration detection in suspensions of polymer and protein samples: Influence of experimental and data evaluation parameters
2016
Effect of trehalose on protein structure
2008 Standout
Progress in Exosome Isolation Techniques
2017 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Bioorthogonal strategies for site-directed decoration of biomaterials with therapeutic proteins
2018
Metastatic colonization by circulating tumour cells
2016 StandoutNature
New developments for antibody-drug conjugate-based therapeutic approaches
2016
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
2010
Role of trehalose in moisture-induced aggregation of bovine serum albumin
2008
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
DLS and zeta potential – What they are and what they are not?
2016 Standout
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
2019
Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody–Drug Conjugation Chemistry
2016
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
2015
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Computational design of a homotrimeric metalloprotein with a trisbipyridyl core
2016 StandoutNobel
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
2011
Regulation of Apoptosis by HER2 in Breast Cancer
2013
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
2010
Effect of oxidation on the emulsifying properties of soy protein isolate
2013
Camelina uses, genetics, genomics, production, and management
2016 Standout
Adhesion properties of camelina protein fractions isolated with different methods
2015
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate
2015
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy
2010
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Nanomedicine(s) under the Microscope
2011
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Design of Antibody−Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism
2011
Soy proteins: A review on composition, aggregation and emulsification
2014 Standout
Antibody-Drug Conjugates in Cancer Therapy
2012
Natural product and natural product derived drugs in clinical trials
2014 Standout
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Acid-Induced Aggregation of Human Monoclonal IgG1 and IgG2: Molecular Mechanism and the Effect of Solution Composition
2010
Emerging Targets in Photopharmacology
2016 StandoutNobel
Dynamic Reorganization of Metabolic Enzymes into Intracellular Bodies
2012
Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates
2009
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
2013
Semisynthesis of an Active Enzyme by Quantitative Click Ligation
2019 StandoutNobel
Computational design of a pH-sensitive IgG binding protein
2013 StandoutNobel
Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody–Drug Conjugates
2015
A REVIEW SIZE-EXCLUSION CHROMATOGRAPHY FOR THE ANALYSIS OF PROTEIN BIOTHERAPEUTICS AND THEIR AGGREGATES
2012
The Biomedical Use of Silk: Past, Present, Future
2018 Standout
PK Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab Emtansine
2013
Works of Fred Jacobson being referenced
Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate
2014
Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer
2010
Protein aggregation and bioprocessing
2006
Anti-CD22-MCC-DM1 and MC-MMAF Conjugates: Impact of Assay Format on Pharmacokinetic Parameters Determination
2008